Neurometabolite changes in response to antidepressant medication: A systematic review of 1H-MRS findings
•SSRIs and SNRIs do not consistently affect Glu/GABA systems in 1H-MRS studies.•Amidst null findings, we find some evidence that (es)ketamine increases ACC Glu.•Standardization of study-, and acquisition protocols for 1H-MRS is essential. Selective serotonin reuptake inhibitors (SSRIs), serotonin an...
Saved in:
| Published in | NeuroImage clinical Vol. 40; p. 103517 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier Inc
01.01.2023
Elsevier |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2213-1582 2213-1582 |
| DOI | 10.1016/j.nicl.2023.103517 |
Cover
Loading…
| Abstract | •SSRIs and SNRIs do not consistently affect Glu/GABA systems in 1H-MRS studies.•Amidst null findings, we find some evidence that (es)ketamine increases ACC Glu.•Standardization of study-, and acquisition protocols for 1H-MRS is essential.
Selective serotonin reuptake inhibitors (SSRIs), serotonin and noradrenaline reuptake inhibitors (SNRIs), and (es)ketamine are used to treat major depressive disorder (MDD). These different types of medication may involve common neural pathways related to glutamatergic and GABAergic neurotransmitter systems, both of which have been implicated in MDD pathology. We conducted a systematic review of pharmacological proton Magnetic Resonance Spectroscopy (1H-MRS) studies in healthy volunteers and individuals with MDD to explore the potential impact of these medications on glutamatergic and GABAergic systems. We searched PubMed, Web of Science and Embase and included randomized controlled trials or cohort studies, which assessed the effects of SSRIs, SNRIs, or (es)ketamine on glutamate, glutamine, Glx or GABA using single-voxel 1H-MRS or Magnetic Resonance Spectroscopic Imaging (MRSI). Additionally, studies were included when they used a field strength > 1.5 T, and when a comparison of metabolite levels between antidepressant treatment and placebo or baseline with post-medication metabolite levels was done. We excluded animal studies, duplicate publications, or articles with 1H-MRS data already described in another included article. Twenty-nine studies were included in this review. Fifteen studies investigated the effect of administration or treatment with SSRIs or SNRIs, and fourteen studies investigated the effect of (es)ketamine on glutamatergic and GABAergic metabolite levels. Studies on SSRIs and SNRIs were highly variable, generally underpowered, and yielded no consistent findings across brain regions or specific populations. Although studies on (es)ketamine were also highly variable, some demonstrated an increase in glutamate levels in the anterior cingulate cortex in a time-dependent manner after administration. Our findings highlight the need for standardized study and acquisition protocols. Additionally, measuring metabolites dynamically over time or combining 1H-MRS with whole brain functional imaging techniques could provide valuable insights into the effects of these medications on glutamate and GABAergic neurometabolism. |
|---|---|
| AbstractList | Highlights•SSRIs and SNRIs do not consistently affect Glu/GABA systems in 1H-MRS studies. •Amidst null findings, we find some evidence that (es)ketamine increases ACC Glu. •Standardization of study-, and acquisition protocols for 1H-MRS is essential. Selective serotonin reuptake inhibitors (SSRIs), serotonin and noradrenaline reuptake inhibitors (SNRIs), and (es)ketamine are used to treat major depressive disorder (MDD). These different types of medication may involve common neural pathways related to glutamatergic and GABAergic neurotransmitter systems, both of which have been implicated in MDD pathology. We conducted a systematic review of pharmacological proton Magnetic Resonance Spectroscopy (1H-MRS) studies in healthy volunteers and individuals with MDD to explore the potential impact of these medications on glutamatergic and GABAergic systems. We searched PubMed, Web of Science and Embase and included randomized controlled trials or cohort studies, which assessed the effects of SSRIs, SNRIs, or (es)ketamine on glutamate, glutamine, Glx or GABA using single-voxel 1H-MRS or Magnetic Resonance Spectroscopic Imaging (MRSI). Additionally, studies were included when they used a field strength > 1.5 T, and when a comparison of metabolite levels between antidepressant treatment and placebo or baseline with post-medication metabolite levels was done. We excluded animal studies, duplicate publications, or articles with 1H-MRS data already described in another included article. Twenty-nine studies were included in this review. Fifteen studies investigated the effect of administration or treatment with SSRIs or SNRIs, and fourteen studies investigated the effect of (es)ketamine on glutamatergic and GABAergic metabolite levels. Studies on SSRIs and SNRIs were highly variable, generally underpowered, and yielded no consistent findings across brain regions or specific populations. Although studies on (es)ketamine were also highly variable, some demonstrated an increase in glutamate levels in the anterior cingulate cortex in a time-dependent manner after administration. Our findings highlight the need for standardized study and acquisition protocols. Additionally, measuring metabolites dynamically over time or combining 1H-MRS with whole brain functional imaging techniques could provide valuable insights into the effects of these medications on glutamate and GABAergic neurometabolism.Selective serotonin reuptake inhibitors (SSRIs), serotonin and noradrenaline reuptake inhibitors (SNRIs), and (es)ketamine are used to treat major depressive disorder (MDD). These different types of medication may involve common neural pathways related to glutamatergic and GABAergic neurotransmitter systems, both of which have been implicated in MDD pathology. We conducted a systematic review of pharmacological proton Magnetic Resonance Spectroscopy (1H-MRS) studies in healthy volunteers and individuals with MDD to explore the potential impact of these medications on glutamatergic and GABAergic systems. We searched PubMed, Web of Science and Embase and included randomized controlled trials or cohort studies, which assessed the effects of SSRIs, SNRIs, or (es)ketamine on glutamate, glutamine, Glx or GABA using single-voxel 1H-MRS or Magnetic Resonance Spectroscopic Imaging (MRSI). Additionally, studies were included when they used a field strength > 1.5 T, and when a comparison of metabolite levels between antidepressant treatment and placebo or baseline with post-medication metabolite levels was done. We excluded animal studies, duplicate publications, or articles with 1H-MRS data already described in another included article. Twenty-nine studies were included in this review. Fifteen studies investigated the effect of administration or treatment with SSRIs or SNRIs, and fourteen studies investigated the effect of (es)ketamine on glutamatergic and GABAergic metabolite levels. Studies on SSRIs and SNRIs were highly variable, generally underpowered, and yielded no consistent findings across brain regions or specific populations. Although studies on (es)ketamine were also highly variable, some demonstrated an increase in glutamate levels in the anterior cingulate cortex in a time-dependent manner after administration. Our findings highlight the need for standardized study and acquisition protocols. Additionally, measuring metabolites dynamically over time or combining 1H-MRS with whole brain functional imaging techniques could provide valuable insights into the effects of these medications on glutamate and GABAergic neurometabolism. Selective serotonin reuptake inhibitors (SSRIs), serotonin and noradrenaline reuptake inhibitors (SNRIs), and (es)ketamine are used to treat major depressive disorder (MDD). These different types of medication may involve common neural pathways related to glutamatergic and GABAergic neurotransmitter systems, both of which have been implicated in MDD pathology. We conducted a systematic review of pharmacological proton Magnetic Resonance Spectroscopy (1H-MRS) studies in healthy volunteers and individuals with MDD to explore the potential impact of these medications on glutamatergic and GABAergic systems. We searched PubMed, Web of Science and Embase and included randomized controlled trials or cohort studies, which assessed the effects of SSRIs, SNRIs, or (es)ketamine on glutamate, glutamine, Glx or GABA using single-voxel 1H-MRS or Magnetic Resonance Spectroscopic Imaging (MRSI). Additionally, studies were included when they used a field strength > 1.5 T, and when a comparison of metabolite levels between antidepressant treatment and placebo or baseline with post-medication metabolite levels was done. We excluded animal studies, duplicate publications, or articles with 1H-MRS data already described in another included article. Twenty-nine studies were included in this review. Fifteen studies investigated the effect of administration or treatment with SSRIs or SNRIs, and fourteen studies investigated the effect of (es)ketamine on glutamatergic and GABAergic metabolite levels. Studies on SSRIs and SNRIs were highly variable, generally underpowered, and yielded no consistent findings across brain regions or specific populations. Although studies on (es)ketamine were also highly variable, some demonstrated an increase in glutamate levels in the anterior cingulate cortex in a time-dependent manner after administration. Our findings highlight the need for standardized study and acquisition protocols. Additionally, measuring metabolites dynamically over time or combining 1H-MRS with whole brain functional imaging techniques could provide valuable insights into the effects of these medications on glutamate and GABAergic neurometabolism. •SSRIs and SNRIs do not consistently affect Glu/GABA systems in 1H-MRS studies.•Amidst null findings, we find some evidence that (es)ketamine increases ACC Glu.•Standardization of study-, and acquisition protocols for 1H-MRS is essential. Selective serotonin reuptake inhibitors (SSRIs), serotonin and noradrenaline reuptake inhibitors (SNRIs), and (es)ketamine are used to treat major depressive disorder (MDD). These different types of medication may involve common neural pathways related to glutamatergic and GABAergic neurotransmitter systems, both of which have been implicated in MDD pathology. We conducted a systematic review of pharmacological proton Magnetic Resonance Spectroscopy (1H-MRS) studies in healthy volunteers and individuals with MDD to explore the potential impact of these medications on glutamatergic and GABAergic systems. We searched PubMed, Web of Science and Embase and included randomized controlled trials or cohort studies, which assessed the effects of SSRIs, SNRIs, or (es)ketamine on glutamate, glutamine, Glx or GABA using single-voxel 1H-MRS or Magnetic Resonance Spectroscopic Imaging (MRSI). Additionally, studies were included when they used a field strength > 1.5 T, and when a comparison of metabolite levels between antidepressant treatment and placebo or baseline with post-medication metabolite levels was done. We excluded animal studies, duplicate publications, or articles with 1H-MRS data already described in another included article. Twenty-nine studies were included in this review. Fifteen studies investigated the effect of administration or treatment with SSRIs or SNRIs, and fourteen studies investigated the effect of (es)ketamine on glutamatergic and GABAergic metabolite levels. Studies on SSRIs and SNRIs were highly variable, generally underpowered, and yielded no consistent findings across brain regions or specific populations. Although studies on (es)ketamine were also highly variable, some demonstrated an increase in glutamate levels in the anterior cingulate cortex in a time-dependent manner after administration. Our findings highlight the need for standardized study and acquisition protocols. Additionally, measuring metabolites dynamically over time or combining 1H-MRS with whole brain functional imaging techniques could provide valuable insights into the effects of these medications on glutamate and GABAergic neurometabolism. •SSRIs and SNRIs do not consistently affect Glu/GABA systems in 1H-MRS studies.•Amidst null findings, we find some evidence that (es)ketamine increases ACC Glu.•Standardization of study-, and acquisition protocols for 1H-MRS is essential. Selective serotonin reuptake inhibitors (SSRIs), serotonin and noradrenaline reuptake inhibitors (SNRIs), and (es)ketamine are used to treat major depressive disorder (MDD). These different types of medication may involve common neural pathways related to glutamatergic and GABAergic neurotransmitter systems, both of which have been implicated in MDD pathology. We conducted a systematic review of pharmacological proton Magnetic Resonance Spectroscopy (1H-MRS) studies in healthy volunteers and individuals with MDD to explore the potential impact of these medications on glutamatergic and GABAergic systems. We searched PubMed, Web of Science and Embase and included randomized controlled trials or cohort studies, which assessed the effects of SSRIs, SNRIs, or (es)ketamine on glutamate, glutamine, Glx or GABA using single-voxel 1H-MRS or Magnetic Resonance Spectroscopic Imaging (MRSI). Additionally, studies were included when they used a field strength >1.5T, and when a comparison of metabolite levels between antidepressant treatment and placebo or baseline with post-medication metabolite levels was done. We excluded animal studies, duplicate publications, or articles with 1H-MRS data already described in another included article. Twenty-nine studies were included in this review. Fifteen studies investigated the effect of administration or treatment with SSRIs or SNRIs, and fourteen studies investigated the effect of (es)ketamine on glutamatergic and GABAergic metabolite levels. Studies on SSRIs and SNRIs were highly variable, generally underpowered, and yielded no consistent findings across brain regions or specific populations. Although studies on (es)ketamine were also highly variable, some demonstrated an increase in glutamate levels in the anterior cingulate cortex in a time-dependent manner after administration. Our findings highlight the need for standardized study and acquisition protocols. Additionally, measuring metabolites dynamically over time or combining 1H-MRS with whole brain functional imaging techniques could provide valuable insights into the effects of these medications on glutamate and GABAergic neurometabolism. • SSRIs and SNRIs do not consistently affect Glu/GABA systems in 1 H-MRS studies. • Amidst null findings, we find some evidence that (es)ketamine increases ACC Glu. • Standardization of study-, and acquisition protocols for 1 H-MRS is essential. Selective serotonin reuptake inhibitors (SSRIs), serotonin and noradrenaline reuptake inhibitors (SNRIs), and (es)ketamine are used to treat major depressive disorder (MDD). These different types of medication may involve common neural pathways related to glutamatergic and GABAergic neurotransmitter systems, both of which have been implicated in MDD pathology. We conducted a systematic review of pharmacological proton Magnetic Resonance Spectroscopy ( 1 H-MRS) studies in healthy volunteers and individuals with MDD to explore the potential impact of these medications on glutamatergic and GABAergic systems. We searched PubMed, Web of Science and Embase and included randomized controlled trials or cohort studies, which assessed the effects of SSRIs, SNRIs, or (es)ketamine on glutamate, glutamine, Glx or GABA using single-voxel 1 H-MRS or Magnetic Resonance Spectroscopic Imaging (MRSI). Additionally, studies were included when they used a field strength > 1.5 T, and when a comparison of metabolite levels between antidepressant treatment and placebo or baseline with post-medication metabolite levels was done. We excluded animal studies, duplicate publications, or articles with 1 H-MRS data already described in another included article. Twenty-nine studies were included in this review. Fifteen studies investigated the effect of administration or treatment with SSRIs or SNRIs, and fourteen studies investigated the effect of (es)ketamine on glutamatergic and GABAergic metabolite levels. Studies on SSRIs and SNRIs were highly variable, generally underpowered, and yielded no consistent findings across brain regions or specific populations. Although studies on (es)ketamine were also highly variable, some demonstrated an increase in glutamate levels in the anterior cingulate cortex in a time-dependent manner after administration. Our findings highlight the need for standardized study and acquisition protocols. Additionally, measuring metabolites dynamically over time or combining 1 H-MRS with whole brain functional imaging techniques could provide valuable insights into the effects of these medications on glutamate and GABAergic neurometabolism. |
| ArticleNumber | 103517 |
| Author | Schrantee, Anouk Reneman, Liesbeth Ruhé, Henricus G. Boucherie, Daphne E. |
| Author_xml | – sequence: 1 givenname: Daphne E. orcidid: 0000-0002-2976-769X surname: Boucherie fullname: Boucherie, Daphne E. email: d.e.boucherie@amsterdamumc.nl organization: Amsterdam UMC, Location AMC, Department of Radiology and Nuclear Medicine, Meibergdreef 9, 1109 AZ Amsterdam, the Netherlands – sequence: 2 givenname: Liesbeth surname: Reneman fullname: Reneman, Liesbeth organization: Department of Psychiatry, Radboudumc, Radboud University, Reinier Postlaan 4, 6525 GC Nijmegen, the Netherlands – sequence: 3 givenname: Henricus G. surname: Ruhé fullname: Ruhé, Henricus G. organization: Amsterdam UMC, Location AMC, Department of Radiology and Nuclear Medicine, Meibergdreef 9, 1109 AZ Amsterdam, the Netherlands – sequence: 4 givenname: Anouk surname: Schrantee fullname: Schrantee, Anouk organization: Amsterdam UMC, Location AMC, Department of Radiology and Nuclear Medicine, Meibergdreef 9, 1109 AZ Amsterdam, the Netherlands |
| BookMark | eNqFkl1vFCEUhompse3aP-AVl97slo-BYRqjaRq1TaomVq8JC2d2WWdhBbZm_71Mtya2iZUbDofzPhx4OUYHIQZA6BUlM0qoPF3NgrfDjBHGa4IL2j5DR4xRPqVCsYO_4kN0kvOK1KEIaaV8gQ55qyhTojtCy8-wTXENxczj4AtguzRhARn7gBPkTQwZcInYhOIdbGoq1xCvwXlrio_hDJ_jvMsF1nVpq-bWwy8ce0wvp5--3uDeB-fDIr9Ez3szZDi5nyfo-4f33y4up9dfPl5dnF9PreCiTBtHJOWq566xjBvVMSGhn7cArQLRWmVJ54QyxPXWSaG4k1x0sumMbea25XyCrvZcF81Kb5Jfm7TT0Xh9l4hpoU2qnQ6gwXVMsV5abkxDiDOyFQ04yYRSLTVQWe_2rM12Xm9sIZRkhgfQhzvBL_Ui3mpKhOREjN28viek-HMLuei1zxaGwQSI26yZagVXRNbyCVL7Uptizgl6bX25e-KK9kNl6tF4vdKj8Xo0Xu-Nr1L2SPqnxSdFb_YiqG5U05LO1kOw1dkEttTn8k_L3z6S28HXKjP8gB3kVdymUH3WVGemib4Zv-P4GxknhBElKuDs34D_nf4bei7wyQ |
| CitedBy_id | crossref_primary_10_3390_biomedicines12020384 |
| Cites_doi | 10.1093/ijnp/pyy069 10.1016/j.biopsych.2006.09.018 10.1017/S1461145712000272 10.1016/j.neuropharm.2011.07.036 10.3389/fnins.2021.609485 10.1016/S0006-3223(99)00230-9 10.1001/jamapsychiatry.2022.3384 10.1176/appi.ajp.159.4.663 10.1016/j.bbr.2018.10.021 10.1016/j.neuroimage.2021.117913 10.1038/mp.2016.122 10.1016/S0006-3223(00)01036-2 10.1097/00000542-199704000-00021 10.1016/j.ab.2016.06.003 10.1073/pnas.1916570117 10.1523/JNEUROSCI.16-06-02034.1996 10.1007/s11064-012-0848-4 10.1016/j.neuroimage.2004.01.015 10.1001/archpsyc.63.8.856 10.1038/s41386-018-0136-3 10.1016/j.neuron.2005.02.014 10.1016/j.pnpbp.2018.01.021 10.1016/j.jpsychires.2019.07.008 10.1038/jcbfm.2014.233 10.1016/j.ejphar.2012.11.023 10.1016/j.jpsychires.2012.04.018 10.1007/s00406-021-01377-2 10.1016/j.biopsych.2004.06.010 10.1038/mp.2011.171 10.1186/s13643-016-0384-4 10.1177/0269881107081510 10.1176/appi.ajp.162.2.394 10.1016/j.jclinepi.2009.06.005 10.2147/PPA.S29716 10.1177/0269881116636108 10.1177/0269881109105679 10.1016/j.pscychresns.2017.08.009 10.1111/ejn.14618 10.1038/s41380-018-0252-9 10.1002/nbm.4257 10.1038/npp.2016.184 10.1016/j.neulet.2005.08.054 10.1016/j.neuropharm.2015.10.034 10.1016/j.neuroimage.2012.09.037 10.1016/j.biopsych.2016.05.005 10.1007/s11682-022-00756-0 10.1017/S1461145708009516 10.1002/mrm.29456 10.1097/FPC.0b013e32833132cb 10.1523/JNEUROSCI.3021-18.2019 10.1523/JNEUROSCI.1758-13.2013 10.1176/appi.ajp.161.2.368 10.1523/JNEUROSCI.2213-07.2007 10.1038/npp.2010.166 10.1111/bdi.12118 10.1016/S0197-0186(03)00104-9 10.1016/S0924-977X(02)00102-5 10.1007/s00213-014-3687-y 10.1016/j.neuroimage.2012.12.004 10.1016/j.neuroimage.2022.119813 10.1016/j.biopsych.2011.11.006 10.1016/j.pscychresns.2010.10.009 10.1177/0271678X221076570 10.1177/0269881111405359 10.1002/nbm.4236 10.1007/s00213-013-3024-x 10.1016/j.neuropharm.2018.06.008 10.1038/jcbfm.2008.134 10.1523/JNEUROSCI.17-08-02921.1997 10.1111/jon.12345 10.1016/j.neuroimage.2005.02.001 10.1016/j.pnmrs.2011.06.001 10.1055/s-2007-979537 10.1038/s41386-018-0057-1 10.1038/s41398-018-0321-5 10.1016/j.jad.2020.10.011 10.1038/s41380-022-01730-4 10.1016/j.biopsych.2008.08.014 10.1176/ajp.156.5.675 10.1002/hbm.20667 10.1016/j.jad.2020.01.138 10.1038/mp.2015.83 10.1001/jamapsychiatry.2018.0252 10.1001/jamapsychiatry.2017.3572 10.1002/nbm.4484 10.1016/j.biopsych.2010.06.016 10.1016/j.neuroimage.2020.116532 |
| ContentType | Journal Article |
| Copyright | 2023 The Authors The Authors 2023 Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. 2023 The Authors 2023 |
| Copyright_xml | – notice: 2023 The Authors – notice: The Authors – notice: 2023 – notice: Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. – notice: 2023 The Authors 2023 |
| DBID | 6I. AAFTH AAYXX CITATION 7X8 5PM DOA |
| DOI | 10.1016/j.nicl.2023.103517 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2213-1582 |
| EndPage | 103517 |
| ExternalDocumentID | oai_doaj_org_article_ed9282f6c3aa400da6754ed6258871ae PMC10563053 10_1016_j_nicl_2023_103517 S2213158223002085 1_s2_0_S2213158223002085 |
| GroupedDBID | .1- .FO 0R~ 1P~ 457 53G 5VS AAEDT AAEDW AAIKJ AALRI AAXUO AAYWO ABMAC ACGFS ACVFH ADBBV ADCNI ADEZE ADRAZ ADVLN AEUPX AEXQZ AFJKZ AFPUW AFRHN AFTJW AGHFR AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS APXCP BAWUL BCNDV DIK EBS EJD FDB GROUPED_DOAJ HYE HZ~ IPNFZ IXB KQ8 M41 M48 M~E O-L O9- OK1 RIG ROL RPM SSZ Z5R 0SF 6I. AACTN AAFTH AFCTW NCXOZ AAYXX CITATION 7X8 5PM |
| ID | FETCH-LOGICAL-c535t-4d06138f3d4c23a89256efb7ee78e57c8c09d58a0dfcd6583d6359649ac4bc733 |
| IEDL.DBID | M48 |
| ISSN | 2213-1582 |
| IngestDate | Wed Aug 27 01:07:27 EDT 2025 Thu Aug 21 18:35:42 EDT 2025 Thu Jul 10 22:13:32 EDT 2025 Tue Jul 01 01:09:54 EDT 2025 Thu Apr 24 23:07:38 EDT 2025 Sat Sep 30 17:11:04 EDT 2023 Tue Feb 25 20:05:20 EST 2025 Tue Aug 26 16:33:11 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | SSRI 1H-MRS (es)ketamine SNRI GABA Glutamate Major Depressive Disorder glutamate |
| Language | English |
| License | This is an open access article under the CC BY license. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c535t-4d06138f3d4c23a89256efb7ee78e57c8c09d58a0dfcd6583d6359649ac4bc733 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 ObjectType-Review-4 content type line 23 |
| ORCID | 0000-0002-2976-769X |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1016/j.nicl.2023.103517 |
| PMID | 37812859 |
| PQID | 2875380656 |
| PQPubID | 23479 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_ed9282f6c3aa400da6754ed6258871ae pubmedcentral_primary_oai_pubmedcentral_nih_gov_10563053 proquest_miscellaneous_2875380656 crossref_citationtrail_10_1016_j_nicl_2023_103517 crossref_primary_10_1016_j_nicl_2023_103517 elsevier_sciencedirect_doi_10_1016_j_nicl_2023_103517 elsevier_clinicalkeyesjournals_1_s2_0_S2213158223002085 elsevier_clinicalkey_doi_10_1016_j_nicl_2023_103517 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-01-01 |
| PublicationDateYYYYMMDD | 2023-01-01 |
| PublicationDate_xml | – month: 01 year: 2023 text: 2023-01-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationTitle | NeuroImage clinical |
| PublicationYear | 2023 |
| Publisher | Elsevier Inc Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier |
| References | Milak, Proper, Mulhern, Parter, Kegeles, Ogden, Mao, Rodriguez, Oquendo, Suckow, Cooper, Keilp, Shungu, Mann (b0255) 2016; 21 Spurny, Vanicek, Seiger, Reed, Klöbl, Ritter, Unterholzner, Godbersen, Silberbauer, Pacher, Klug, Konadu, Gryglewski, Trattnig, Bogner, Lanzenberger (b0420) 2021; 232 Dou, Palomero-Gallagher, van Tol, Kaufmann, Zhong, Bernstein, Heinze, Speck, Walter (b0100) 2013; 33 Grunze, Rainnie, Hasselmo, Barkai, Hearn, McCarley, Greene (b0145) 1996; 16 Block, Träber, Von Widdern, Metten, Schild, Maier, Zobel, Jessen (b0050) 2009; 12 Keilhoff, Bernstein, Becker, Grecksch, Wolf (b0175) 2004; 56 Orser, Pennefather, MacDonald (b0310) 1997; 86 Sangkuhl, Klein, Altman (b0395) 2009; 19 Godlewska, Near, Cowen (b0130) 2015; 232 Berman, Cappiello, Anand, Oren, Heninger, Charney, Krystal (b0030) 2000; 47 Maron, Near, Wallis, Stokes, Matthews, Nutt (b0235) 2016; 30 Peek, Rebbeck, Puts, Watson, Aguila, Leaver (b0330) 2020; 210 Chowdhury, Behar, Cho, Thomas, Rothman, Sanacora (b0080) 2012; 71 Sanacora, Treccani, Popoli (b0385) 2012; 62 Kozel, Rao, Lu, Nakonezny, Grannemann, McGregor, Croarkin, Mapes, Tamminga, Trivedi (b0195) 2011; 2 Salvadore, Zarate (b0375) 2010; 68 Seminowicz, Mayberg, Mcintosh, Goldapple, Kennedy, Segal, Rafi-tari (b0400) 2004; 22 Chen, Ridler, Suckling, Williams, Fu, Merlo-Pich, Bullmore (b0075) 2007; 62 Rowland, Bustillo, Mullins, Jung, Lenroot, Landgraf, Barrow, Yeo, Lauriello, Brooks (b0365) 2005; 162 Moriguchi, Takamiya, Noda, Horita, Wada, Tsugawa, Plitman, Sano, Tarumi, ElSalhy, Katayama, Ogyu, Miyazaki, Kishimoto, Graff-Guerrero, Meyer, Blumberger, Daskalakis, Mimura, Nakajima (b0275) 2019; 24 Björkholm, Monteggia (b0045) 2016; 102 Kraguljac, Frölich, Tran, White, Nichols, Barton-Mcardle, Reid, Bolding, Lahti (b0200) 2017; 22 Moaddel, Abdrakhmanova, Kozak, Jozwiak, Jimenez, Rosenberg, Tran, Xiao, Zarate, Wainer (b0260) 2014; 698 Sanacora, Mason, Rothman, Krystal (b0380) 2002; 159 Gärtner, Weigand, Scheidegger, Lehmann, Wyss, Wunder, Henning, Grimm (b0120) 2022; 272 Mangia, Giove, DiNuzzo (b0230) 2012; 37 Salvadore, Cornwell, Colon-Rosario, Coppola, Grillon, Zarate, Manji (b0370) 2009; 65 De Simoni, Schwarz, O’Daly, Marquand, Brittain, Gonzales, Stephenson, Williams, Mehta (b0095) 2013; 64 Palomero-Gallagher, Vogt, Schleider, Mayberg, Zilles (b0325) 2009; 30 Al-Harbi (b0010) 2012; 6 Bednařík, Tkáč, Giove, Dinuzzo, Deelchand, Emir, Eberly, Mangia (b0025) 2015; 35 Colic, McDonnell, Li, Woelfer, Liebe, Kretzschmar, Speck, Schott, Bianchi, Walter (b0090) 2019; 359 Puts, Edden (b0350) 2012; 60 Brennan, Admon, Perriello, LaFlamme, Athey, Pizzagalli, Hudson, Pope, Jensen (b0060) 2017; 269 Zarate, Singh, Carlson, Brutsche, Ameli, Luckenbaugh, Charney, Manji (b0480) 2006; 63 Valentine, Mason, Gomez, Fasula, Watzl, Pittman, Krystal, Sanacora (b0470) 2011; 191 Evans, Lally, An, Li, Nugent, Banerjee, Snider, Shen, Roiser, Zarate (b0115) 2018; 43 Skolnick, Layer, Popik, Nowak, Paul, Trullas (b0410) 1996; 29 Kokkinou, Ashok, Howes (b0185) 2017; 23 Taylor, Norbury, Murphy, Rudebeck, Jezzard, Cowen (b0455) 2010; 24 Godlewska, Browning, Norbury, Igoumenou, Cowen, Harmer (b0135) 2018; 21 Near, Harris, Juchem, Kreis, Marjańska, Öz, Slotboom, Wilson, Gasparovic (b0295) 2021; 34 Koush, Rothman, Behar, de Graaf, Hyder (b0190) 2022; 42 Stone, Dietrich, Edden, Mehta, De Simoni, Reed, Krystal, Nutt, Barker (b0430) 2012; 17 Nugent, Diazgranados, Carlson, Ibrahim, Luckenbaugh, Brutsche, Herscovitch, Drevets, Zarate (b0305) 2014; 16 Tso, Blatchford, Callado, McLaughlin, Stamford (b0465) 2004; 44 Drevets, Bogers, Raichle (b0110) 2002; 12 Taylor, Murphy, Selvaraj, Wylezinkska, Jezzard, Cowen, Evans (b0450) 2008; 22 Gigliucci, O’Dowd, Casey, Egan, Gibney, Harkin (b0125) 2013; 228 Arnone, Wise, Walker, Cowen, Howes, Selvaraj (b0015) 2018; 84 Tal (b0440) 2023; 89 Mullins, McGonigle, O’Gorman, Puts, Vidyasagar, Evans, Edden, Brookes, Garcia, Foerster, Petrou, Price, Solanky, Violante, Williams, Wilson (b0285) 2014; 86 Lener, Niciu, Ballard, Park, Park, Nugent, Zarate (b0210) 2017; 81 Klein, Chandra, Sheriff, Malinow (b0180) 2020; 117 Buck, Cali, Behr (b0070) 2006; 392 Mangia, Giove, Tkáč, Logothetis, Henry, Olman, Maraviglia, Di Salle, Uǧurbil (b0225) 2009; 29 Lea-Carnall, El-Deredy, Stagg, Williams, Trujillo-Barreto (b0205) 2023; 266 Mullins, Rowland, Jung, Sibbitt (b0280) 2005; 26 Ramirez-Mahaluf, Roxin, Mayberg, Compte (b0355) 2017; 27 Ng, Huang, Han, Chang, Chan, Lai (b0300) 2018; 8 Clarke, W.T., Ligneul, C., Cottaar, M., Jbabdi, S., 2022. Dynamic fitting of functional MRS, diffusion weighted MRS, and edited MRS using a single interface [conference abstract], in: International Society for Magnetic Resonance in Medicine. Taylor, Godlewska, Norbury, Selvaraj, Near, Cowen (b0445) 2012; 15 Moghaddam, Adams, Verma, Daly (b0265) 1997; 17 Hansen, Olesen, Simonsen, Fischer, Lelic, Drewes, Frøkjær (b0150) 2016; 26 Betina Ip, Emir, Parker, Campbell, Bridge (b0035) 2019; 39 Mayberg, Liotti, Brannan, McGinnis, Mahurin, Jerabek, Silva, Tekell, Martin, Lancaster, Fox (b0240) 1999; 5 Abdallah, De Feyter, Averill, Jiang, Averill, Chowdhury, Purohit, de Graaf, Esterlis, Juchem, Pittman, Krystal, Rothman, Sanacora, Mason (b0005) 2018; 43 Ouzzani, Hammady, Fedorowicz, Elmagarmid (b0315) 2016; 5 Bhagwagar, Wylezinska, Taylor, Jezzard, Matthews, Cowen (b0040) 2004; 161 Li, Demenescu, Colic, Metzger, Heinze, Steiner, Speck, Fejtova, Salvadore, Walter (b0215) 2017; 42 Narayan, Hill, Wengler, He, Wang, Yang, Parsey, DeLorenzo (b0290) 2022; 27 Öz, Deelchand, Wijnen, Mlynárik, Xin, Mekle, Noeske, Scheenen, Tkáč, Andronesi, Barker, Bartha, Berrington, Boer, Cudalbu, Emir, Ernst, Fillmer, Heerschap, Henry, Hurd, Joers, Juchem, Kan, Klomp, Kreis, Landheer, Mangia, Marjańska, Near, Ratai, Ronen, Slotboom, Soher, Terpstra, Valette, Van der Graaf, Wilson (b0320) 2021; 34 Draganov, Vives-Gilabert, de Diego-Adeliño, Vicent-Gil, Puigdemont, Portella (b0105) 2020; 266 Strege, Siegle, Richey, Krawczak, Young (b0435) 2023; 17 Mayberg, Brannan, Tekell, Silva, Mahurin, McGinnis, Jerabek (b0245) 2000; 48 Silberbauer, Spurny, Handschuh, Klöbl, Bednarik, Reiter, Ritter, Trost, Konadu, Windpassinger, Stimpfl, Bogner, Lanzenberger, Spies (b0405) 2020; 11 Ritter, Buchmann, Müller, Volleberg, Haynes, Ghisleni, Noeske, Tuura, Hasler (b0360) 2022; 79 Sanaei Nezhad, Lea-carnall Adriana, Anton, Jung, Michou, Williams, Parkes (b0390) 2019; 51 Stanley, Raz (b0425) 2018; 9 Taylor, Tiangga, Mhuircheartaigh, Cowen (b0460) 2012; 26 Bryant, Frölich, Tran, Reid, Lahti, Kraguljac (b0065) 2019; 117 Juchem, de Graaf (b0170) 2017; 529 Moher, Liberati, Tetzlaff, Altman (b0270) 2009; 62 Yüksel, Öngür (b0475) 2010; 68 Grimm, Luborzewski, Schubert, Merkl, Kronenberg, Colla, Heuser, Bajbouj (b0140) 2012; 46 Javitt, Carter, Krystal, Kantrowitz, Girgis, Kegeles, Ragland, Maddock, Lesh, Tanase, Corlett, Rothman, Mason, Qiu, Robinson, Potter, Carlson, Wall, Choo, Grinband, Lieberman (b0165) 2018; 75 Mayberg, Lozano, Voon, Mcneely, Seminowicz, Hamani, Schwalb, Kennedy (b0250) 2005; 45 Pizzagalli, Webb, Dillon, Tenke, Kayser, Goer, Fava, McGrath, Weissman, Parsey, Adams, Trombello, Cooper, Deldin, Oquendo, McInnis, Carmody, Bruder, Trivedi (b0345) 2018; 75 Lin, Andronesi, Bogner, Choi, Coello, Cudalbu, Juchem, Kemp, Kreis, Krššák, Lee, Maudsley, Meyerspeer, Mlynarik, Near, Öz, Peek, Puts, Ratai, Tkáč, Mullins (b0220) 2021; 34 Bednarik, Spurny, Silberbauer, Svatkova, Handschuh, Reiter, Konadu, Stimpfl, Spies, Bogner, Lanzenberger (b0020) 2021; 15 Smith, Oeltzschner, Gould, Leoutsakos, Nassery, Joo, Kraut, Edden, Barker, Wijtenburg, Rowland, Workman (b0415) 2021; 279 Pizzagalli (b0340) 2011; 36 Ingram, Kang, Lightman, Jane, Bortolotto, Collingridge, Lodge, Volianskis (b0160) 2018; 142 Homayoun, Moghaddam (b0155) 2007; 27 Bojesen, Andersen, Rasmussen, Baandrup, Madsen, Glenthøj, Rostrup, Broberg (b0055) 2018; 9 Peek, Rebbeck, Puts, Watson, Aguila, Leaver (b0335) 2020; 210 Clarke, Ligneul, Cottaar, Jbabdi (b0085) 2022 Betina Ip (10.1016/j.nicl.2023.103517_b0035) 2019; 39 Block (10.1016/j.nicl.2023.103517_b0050) 2009; 12 Klein (10.1016/j.nicl.2023.103517_b0180) 2020; 117 Narayan (10.1016/j.nicl.2023.103517_b0290) 2022; 27 Bhagwagar (10.1016/j.nicl.2023.103517_b0040) 2004; 161 Ramirez-Mahaluf (10.1016/j.nicl.2023.103517_b0355) 2017; 27 Rowland (10.1016/j.nicl.2023.103517_b0365) 2005; 162 Keilhoff (10.1016/j.nicl.2023.103517_b0175) 2004; 56 Mangia (10.1016/j.nicl.2023.103517_b0230) 2012; 37 Taylor (10.1016/j.nicl.2023.103517_b0445) 2012; 15 Evans (10.1016/j.nicl.2023.103517_b0115) 2018; 43 De Simoni (10.1016/j.nicl.2023.103517_b0095) 2013; 64 Nugent (10.1016/j.nicl.2023.103517_b0305) 2014; 16 Moghaddam (10.1016/j.nicl.2023.103517_b0265) 1997; 17 Kokkinou (10.1016/j.nicl.2023.103517_b0185) 2017; 23 Draganov (10.1016/j.nicl.2023.103517_b0105) 2020; 266 Gärtner (10.1016/j.nicl.2023.103517_b0120) 2022; 272 Skolnick (10.1016/j.nicl.2023.103517_b0410) 1996; 29 Lin (10.1016/j.nicl.2023.103517_b0220) 2021; 34 Salvadore (10.1016/j.nicl.2023.103517_b0375) 2010; 68 Kozel (10.1016/j.nicl.2023.103517_b0195) 2011; 2 Al-Harbi (10.1016/j.nicl.2023.103517_b0010) 2012; 6 Bednařík (10.1016/j.nicl.2023.103517_b0025) 2015; 35 Tal (10.1016/j.nicl.2023.103517_b0440) 2023; 89 Kraguljac (10.1016/j.nicl.2023.103517_b0200) 2017; 22 Mayberg (10.1016/j.nicl.2023.103517_b0245) 2000; 48 Mayberg (10.1016/j.nicl.2023.103517_b0240) 1999; 5 Strege (10.1016/j.nicl.2023.103517_b0435) 2023; 17 Bojesen (10.1016/j.nicl.2023.103517_b0055) 2018; 9 Lea-Carnall (10.1016/j.nicl.2023.103517_b0205) 2023; 266 Li (10.1016/j.nicl.2023.103517_b0215) 2017; 42 Near (10.1016/j.nicl.2023.103517_b0295) 2021; 34 Puts (10.1016/j.nicl.2023.103517_b0350) 2012; 60 Hansen (10.1016/j.nicl.2023.103517_b0150) 2016; 26 Godlewska (10.1016/j.nicl.2023.103517_b0130) 2015; 232 Grunze (10.1016/j.nicl.2023.103517_b0145) 1996; 16 Ng (10.1016/j.nicl.2023.103517_b0300) 2018; 8 Salvadore (10.1016/j.nicl.2023.103517_b0370) 2009; 65 Grimm (10.1016/j.nicl.2023.103517_b0140) 2012; 46 Taylor (10.1016/j.nicl.2023.103517_b0455) 2010; 24 Moher (10.1016/j.nicl.2023.103517_b0270) 2009; 62 Abdallah (10.1016/j.nicl.2023.103517_b0005) 2018; 43 Taylor (10.1016/j.nicl.2023.103517_b0460) 2012; 26 Björkholm (10.1016/j.nicl.2023.103517_b0045) 2016; 102 Moaddel (10.1016/j.nicl.2023.103517_b0260) 2014; 698 Ouzzani (10.1016/j.nicl.2023.103517_b0315) 2016; 5 Drevets (10.1016/j.nicl.2023.103517_b0110) 2002; 12 Mayberg (10.1016/j.nicl.2023.103517_b0250) 2005; 45 Pizzagalli (10.1016/j.nicl.2023.103517_b0340) 2011; 36 Homayoun (10.1016/j.nicl.2023.103517_b0155) 2007; 27 Milak (10.1016/j.nicl.2023.103517_b0255) 2016; 21 Orser (10.1016/j.nicl.2023.103517_b0310) 1997; 86 Peek (10.1016/j.nicl.2023.103517_b0330) 2020; 210 Mangia (10.1016/j.nicl.2023.103517_b0225) 2009; 29 Javitt (10.1016/j.nicl.2023.103517_b0165) 2018; 75 Arnone (10.1016/j.nicl.2023.103517_b0015) 2018; 84 Juchem (10.1016/j.nicl.2023.103517_b0170) 2017; 529 Maron (10.1016/j.nicl.2023.103517_b0235) 2016; 30 Buck (10.1016/j.nicl.2023.103517_b0070) 2006; 392 Mullins (10.1016/j.nicl.2023.103517_b0285) 2014; 86 Taylor (10.1016/j.nicl.2023.103517_b0450) 2008; 22 Berman (10.1016/j.nicl.2023.103517_b0030) 2000; 47 Brennan (10.1016/j.nicl.2023.103517_b0060) 2017; 269 Gigliucci (10.1016/j.nicl.2023.103517_b0125) 2013; 228 Koush (10.1016/j.nicl.2023.103517_b0190) 2022; 42 Chowdhury (10.1016/j.nicl.2023.103517_b0080) 2012; 71 Mullins (10.1016/j.nicl.2023.103517_b0280) 2005; 26 Colic (10.1016/j.nicl.2023.103517_b0090) 2019; 359 Valentine (10.1016/j.nicl.2023.103517_b0470) 2011; 191 Tso (10.1016/j.nicl.2023.103517_b0465) 2004; 44 Godlewska (10.1016/j.nicl.2023.103517_b0135) 2018; 21 Sanaei Nezhad (10.1016/j.nicl.2023.103517_b0390) 2019; 51 Palomero-Gallagher (10.1016/j.nicl.2023.103517_b0325) 2009; 30 Pizzagalli (10.1016/j.nicl.2023.103517_b0345) 2018; 75 Silberbauer (10.1016/j.nicl.2023.103517_b0405) 2020; 11 Bednarik (10.1016/j.nicl.2023.103517_b0020) 2021; 15 Stanley (10.1016/j.nicl.2023.103517_b0425) 2018; 9 Bryant (10.1016/j.nicl.2023.103517_b0065) 2019; 117 Yüksel (10.1016/j.nicl.2023.103517_b0475) 2010; 68 Ritter (10.1016/j.nicl.2023.103517_b0360) 2022; 79 Sanacora (10.1016/j.nicl.2023.103517_b0385) 2012; 62 Sanacora (10.1016/j.nicl.2023.103517_b0380) 2002; 159 Chen (10.1016/j.nicl.2023.103517_b0075) 2007; 62 10.1016/j.nicl.2023.103517_b0085 Stone (10.1016/j.nicl.2023.103517_b0430) 2012; 17 Dou (10.1016/j.nicl.2023.103517_b0100) 2013; 33 Ingram (10.1016/j.nicl.2023.103517_b0160) 2018; 142 Seminowicz (10.1016/j.nicl.2023.103517_b0400) 2004; 22 Smith (10.1016/j.nicl.2023.103517_b0415) 2021; 279 Zarate (10.1016/j.nicl.2023.103517_b0480) 2006; 63 Moriguchi (10.1016/j.nicl.2023.103517_b0275) 2019; 24 Öz (10.1016/j.nicl.2023.103517_b0320) 2021; 34 Lener (10.1016/j.nicl.2023.103517_b0210) 2017; 81 Spurny (10.1016/j.nicl.2023.103517_b0420) 2021; 232 Sangkuhl (10.1016/j.nicl.2023.103517_b0395) 2009; 19 |
| References_xml | – volume: 39 start-page: 7968 year: 2019 end-page: 7975 ident: b0035 article-title: Comparison of neurochemical and BOLD signal contrast response functions in the human visual cortex publication-title: J. Neurosci. – volume: 26 start-page: 642 year: 2005 end-page: 646 ident: b0280 article-title: A novel technique to study the brain’s response to pain: Proton Magnetic Resonance Spectroscopy publication-title: Neuroimage – volume: 162 start-page: 394 year: 2005 end-page: 396 ident: b0365 article-title: Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: A 4-T proton MRS study publication-title: Am. J. Psychiatry – volume: 62 start-page: 1006 year: 2009 end-page: 1012 ident: b0270 article-title: Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement publication-title: J. Clin. Epidemiol. – volume: 36 start-page: 183 year: 2011 end-page: 206 ident: b0340 article-title: Frontocingulate dysfunction in depression: Toward biomarkers of treatment response publication-title: Neuropsychopharmacology – volume: 47 start-page: 351 year: 2000 end-page: 354 ident: b0030 article-title: Antidepressant effects of ketamine in depressed patients publication-title: Biol. Psychiatry – volume: 64 start-page: 75 year: 2013 end-page: 90 ident: b0095 article-title: Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers publication-title: Neuroimage – volume: 26 start-page: 733 year: 2012 end-page: 737 ident: b0460 article-title: Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: A proton Magnetic Resonance Spectroscopy study publication-title: J. Psychopharmacol. – volume: 529 start-page: 17 year: 2017 end-page: 29 ident: b0170 article-title: B0 magnetic field homogeneity and shimming for in vivo Magnetic Resonance Spectroscopy publication-title: Anal. Biochem. – volume: 23 start-page: 59 year: 2017 end-page: 69 ident: b0185 article-title: The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders publication-title: Nat. Publ. Gr. – volume: 29 start-page: 23 year: 1996 end-page: 26 ident: b0410 article-title: Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: Implications for the pharmacotherapy of depression publication-title: Pharmacopsychiatry – volume: 24 start-page: 1217 year: 2010 end-page: 1221 ident: b0455 article-title: Lack of effect of citalopram on Magnetic Resonance Spectroscopy measures of glutamate and glutamine in frontal cortex of healthy volunteers publication-title: J. Psychopharmacol. – volume: 15 start-page: 1 year: 2021 end-page: 9 ident: b0020 article-title: Effect of Ketamine on Human Neurochemistry in Posterior Cingulate Cortex: A Pilot Magnetic Resonance Spectroscopy Study at 3 Tesla publication-title: Front. Neurosci. – volume: 43 start-page: 2154 year: 2018 end-page: 2160 ident: b0005 article-title: The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects publication-title: Neuropsychopharmacology – volume: 266 start-page: 572 year: 2020 end-page: 577 ident: b0105 article-title: Glutamatergic and GABA-ergic abnormalities in First-episode depression. A 1-year follow-up 1H-MR Spectroscopic study publication-title: J. Affect. Disord. – volume: 51 start-page: 1784 year: 2019 end-page: 1793 ident: b0390 article-title: Number of subjects required in common study designs for functional GABA Magnetic Resonance Spectroscopy in the human brain at 3 Tesla publication-title: Eur. J. Neurosci. – volume: 392 start-page: 5 year: 2006 end-page: 9 ident: b0070 article-title: Enhancement of long-term potentiation at CA1-subiculum synapses in MK-801-treated rats publication-title: Neurosci. Lett. – volume: 279 start-page: 417 year: 2021 end-page: 425 ident: b0415 article-title: Neurotransmitters and Neurometabolites in Late-Life Depression: A Preliminary Magnetic Resonance Spectroscopy Study at 7T publication-title: J. Affect. Disord. – volume: 44 start-page: 1 year: 2004 end-page: 7 ident: b0465 article-title: Stereoselective effects of ketamine on dopamine, serotonin and noradrenaline release and uptake in rat brain slices publication-title: Neurochem. Int. – volume: 33 start-page: 12698 year: 2013 end-page: 12704 ident: b0100 article-title: Systematic regional variations of GABA, glutamine, and glutamate concentrations follow receptor fingerprints of human cingulate cortex publication-title: J. Neurosci. – volume: 48 start-page: 830 year: 2000 end-page: 843 ident: b0245 article-title: Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response publication-title: Biol. Psychiatry – volume: 27 start-page: 11496 year: 2007 end-page: 11500 ident: b0155 article-title: NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons publication-title: J. Neurosci. – volume: 27 start-page: 3833 year: 2022 end-page: 3841 ident: b0290 article-title: Does the change in glutamate to GABA ratio correlate with change in depression severity? A randomized, double-blind clinical trial publication-title: Mol. Psychiatry – volume: 272 start-page: 703 year: 2022 end-page: 714 ident: b0120 article-title: Acute effects of ketamine on the pregenual anterior cingulate: linking spontaneous activation, functional connectivity, and glutamate metabolism publication-title: Eur. Arch. Psychiatry Clin. Neurosci. – volume: 34 start-page: e4257 year: 2021 ident: b0295 article-title: Preprocessing, analysis and quantification in single-voxel Magnetic Resonance Spectroscopy: experts’ consensus recommendations publication-title: NMR Biomed. – volume: 43 start-page: 1908 year: 2018 end-page: 1914 ident: b0115 article-title: 7T 1 H-MRS in major depressive disorder: A Ketamine Treatment Study publication-title: Neuropsychopharmacology – volume: 62 start-page: 407 year: 2007 end-page: 414 ident: b0075 article-title: Brain Imaging Correlates of Depressive Symptom Severity and Predictors of Symptom Improvement After Antidepressant Treatment publication-title: Biol. Psychiatry – volume: 232 start-page: 501 year: 2015 end-page: 507 ident: b0130 article-title: Neurochemistry of major depression: A study using Magnetic Resonance Spectroscopy publication-title: Psychopharmacology (Berl) – volume: 30 start-page: 579 year: 2016 end-page: 580 ident: b0235 article-title: A pilot study of the effect of short-term escitalopram treatment on brain metabolites and gamma-oscillations in healthy subjects publication-title: J. Psychopharmacol. – volume: 266 year: 2023 ident: b0205 article-title: A mean-field model of glutamate and GABA synaptic dynamics for functional MRS publication-title: Neuroimage – volume: 62 start-page: 63 year: 2012 end-page: 77 ident: b0385 article-title: Towards a glutamate hypothesis of depression: An emerging frontier of neuropsychopharmacology for mood disorders publication-title: Neuropharmacology – volume: 161 start-page: 368 year: 2004 end-page: 370 ident: b0040 article-title: Increased Brain GABA Concentrations Following Acute Administration of a Selective Serotonin Reuptake Inhibitor publication-title: Am. J. Psychiatry – volume: 228 start-page: 157 year: 2013 end-page: 166 ident: b0125 article-title: Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism publication-title: Psychopharmacology (Berl) – volume: 68 start-page: 785 year: 2010 end-page: 794 ident: b0475 article-title: Magnetic Resonance Spectroscopy studies of glutamate-related abnormalities in mood disorders publication-title: Biol. Psychiatry – volume: 29 start-page: 441 year: 2009 end-page: 463 ident: b0225 article-title: Metabolic and hemodynamic events after changes in neuronal activity: Current hypotheses, theoretical predictions and in vivo NMR experimental findings publication-title: J. Cereb. Blood Flow Metab. – volume: 68 start-page: 780 year: 2010 end-page: 782 ident: b0375 article-title: Magnetic Resonance Spectroscopy studies of the glutamatergic system in mood disorders: A pathway to diagnosis, novel therapeutics, and personalized medicine? Biol publication-title: Psychiatry – volume: 22 start-page: 473 year: 2008 end-page: 476 ident: b0450 article-title: Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR Spectroscopy publication-title: J. Psychopharmacol. – volume: 117 start-page: 2656 year: 2020 end-page: 2662 ident: b0180 article-title: Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents publication-title: PNAS – volume: 159 start-page: 663 year: 2002 end-page: 665 ident: b0380 article-title: Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors publication-title: Am. J. Psychiatry – volume: 269 start-page: 9 year: 2017 end-page: 16 ident: b0060 article-title: Acute change in anterior cingulate cortex GABA, but not glutamine/glutamate, mediates antidepressant response to citalopram publication-title: Psychiatry Res. - Neuroimaging – volume: 21 start-page: 988 year: 2018 end-page: 996 ident: b0135 article-title: Predicting Treatment Response in Depression: The Role of Anterior Cingulate Cortex publication-title: Int. J. Neuropsychopharmacol. – volume: 8 year: 2018 ident: b0300 article-title: Ketamine and selective activation of parvalbumin interneurons inhibit stress-induced dendritic spine elimination publication-title: Transl. Psychiatry – volume: 24 start-page: 952 year: 2019 end-page: 964 ident: b0275 article-title: Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton Magnetic Resonance Spectroscopy studies publication-title: Mol. Psychiatry – volume: 12 start-page: 527 year: 2002 end-page: 544 ident: b0110 article-title: Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism publication-title: Eur. Neuropsychopharmacol. – volume: 63 start-page: 793 year: 2006 end-page: 802 ident: b0480 article-title: A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression publication-title: Arch. Gen. Psychiatry – volume: 42 start-page: 911 year: 2022 end-page: 934 ident: b0190 article-title: Human brain functional MRS reveals interplay of metabolites implicated in neurotransmission and neuroenergetics publication-title: J. Cereb. Blood Flow Metab. – volume: 26 start-page: 545 year: 2016 end-page: 551 ident: b0150 article-title: Acute Metabolic Changes Associated With Analgesic Drugs: An MR Spectroscopy Study publication-title: J. Neuroimaging – volume: 46 start-page: 1059 year: 2012 end-page: 1065 ident: b0140 article-title: Region-specific glutamate changes in patients with unipolar depression publication-title: J. Psychiatr. Res. – volume: 86 start-page: 903 year: 1997 end-page: 917 ident: b0310 article-title: Multiple Mechanisms of Ketamine Blockade of N-methyl-D-aspartate Receptors publication-title: Anesthesiology – volume: 86 start-page: 43 year: 2014 end-page: 52 ident: b0285 article-title: Current practice in the use of MEGA-PRESS Spectroscopy for the detection of GABA publication-title: Neuroimage – volume: 34 start-page: 1 year: 2021 end-page: 18 ident: b0220 article-title: Minimum Reporting Standards for in vivo Magnetic Resonance Spectroscopy (MRSinMRS): Experts’ consensus recommendations publication-title: NMR Biomed. – volume: 102 start-page: 72 year: 2016 end-page: 79 ident: b0045 article-title: BDNF - A key transducer of antidepressant effects publication-title: Neuropharmacology – volume: 6 start-page: 369 year: 2012 end-page: 388 ident: b0010 article-title: Treatment-resistant depression: Therapeutic trends, challenges, and future directions publication-title: Patient Prefer. Adherence – volume: 11 start-page: 1 year: 2020 end-page: 11 ident: b0405 article-title: Effect of Ketamine on Limbic GABA and Glutamate: A Human In Vivo Multivoxel Magnetic Resonance Spectroscopy Study publication-title: Front. Psych. – volume: 232 year: 2021 ident: b0420 article-title: Effects of SSRI treatment on GABA and glutamate levels in an associative relearning paradigm publication-title: Neuroimage – volume: 9 year: 2018 ident: b0425 article-title: Functional Magnetic Resonance Spectroscopy: The “new” MRS for cognitive neuroscience and psychiatry research publication-title: Front. Psych. – volume: 75 start-page: 11 year: 2018 end-page: 19 ident: b0165 article-title: Utility of imaging-based biomarkers for glutamate-targeted drug development in psychotic disorders: A randomized clinical trial publication-title: JAMA Psychiat. – volume: 15 start-page: 1541 year: 2012 end-page: 1546 ident: b0445 article-title: Early increase in marker of neuronal integrity with antidepressant treatment of major depression: 1H-Magnetic Resonance Spectroscopy of N-acetyl-aspartate publication-title: Int. J. Neuropsychopharmacol. – volume: 9 start-page: 1 year: 2018 end-page: 10 ident: b0055 article-title: Glutamate levels and resting cerebral blood flow in anterior cingulate cortex are associated at rest and immediately following infusion of S-ketamine in healthy volunteers publication-title: Front. Psych. – volume: 22 start-page: 562 year: 2017 end-page: 569 ident: b0200 article-title: Ketamine modulates hippocampal neurochemistry and functional connectivity: A combined Magnetic Resonance Spectroscopy and resting-state fMRI study in healthy volunteers publication-title: Mol. Psychiatry – volume: 17 start-page: 664 year: 2012 end-page: 665 ident: b0430 article-title: Ketamine effects on brain GABA and glutamate levels with 1H-MRS: Relationship to ketamine-induced psychopathology publication-title: Mol. Psychiatry – volume: 30 start-page: 2336 year: 2009 end-page: 2355 ident: b0325 article-title: Receptor Architecture of Human Cingulate Cortex: Evaluation of the Four-Region Neurobiological Model publication-title: Hum. Brain Mapp. – volume: 142 start-page: 30 year: 2018 end-page: 40 ident: b0160 article-title: Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity publication-title: Neuropharmacology – volume: 37 start-page: 2554 year: 2012 end-page: 2561 ident: b0230 article-title: Metabolic pathways and activity-dependent modulation of glutamate concentration in the human brain publication-title: Neurochem. Res. – volume: 5 start-page: 1 year: 2016 end-page: 10 ident: b0315 article-title: Rayyan-a web and mobile app for systematic reviews publication-title: Syst. Rev. – volume: 698 start-page: 228 year: 2014 end-page: 234 ident: b0260 article-title: Sub-anesthetic concentrations of (R, S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors publication-title: Eur. J. Pharmacol. – volume: 35 start-page: 601 year: 2015 end-page: 610 ident: b0025 article-title: Neurochemical and BOLD responses during neuronal activation measured in the human visual cortex at 7 Tesla publication-title: J. Cereb. Blood Flow Metab. – volume: 191 start-page: 122 year: 2011 end-page: 127 ident: b0470 article-title: The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS publication-title: Psychiatry Res. - Neuroimaging – volume: 210 year: 2020 ident: b0330 article-title: Brain GABA and glutamate levels across pain conditions: A systematic literature review and meta-analysis of 1H-MRS studies using the MRS-Q quality assessment tool publication-title: Neuroimage – volume: 75 start-page: 547 year: 2018 end-page: 554 ident: b0345 article-title: Pretreatment rostral anterior cingulate cortex theta activity in relation to symptom improvement in depression: A randomized clinical trial publication-title: JAMA Psychiat. – volume: 45 start-page: 651 year: 2005 end-page: 660 ident: b0250 article-title: Deep Brain Stimulation for Treatment-Resistant Depression ing electrical stimulation of the subgenual cingulate publication-title: Neuron – volume: 22 start-page: 409 year: 2004 end-page: 418 ident: b0400 article-title: Limbic – frontal circuitry in major depression: a path modeling metanalysis publication-title: Neuroimage – volume: 5 start-page: 675 year: 1999 end-page: 682 ident: b0240 article-title: Reciprocal Limbic-Cortical Function and Negative Mood: Converging PET Findings in Depression and Normal Sadness publication-title: Am. J. Psychiatry – volume: 71 start-page: 1022 year: 2012 end-page: 1025 ident: b0080 article-title: 1H-[13C]-nuclear Magnetic Resonance Spectroscopy measures of ketamine’s effect on amino acid neurotransmitter metabolism publication-title: Biol. Psychiatry – volume: 42 start-page: 1201 year: 2017 end-page: 1209 ident: b0215 article-title: Temporal Dynamics of Antidepressant Ketamine Effects on Glutamine Cycling Follow Regional Fingerprints of AMPA and NMDA Receptor Densities publication-title: Neuropsychopharmacology – volume: 16 start-page: 119 year: 2014 end-page: 128 ident: b0305 article-title: Neural correlates of rapid antidepressant response to ketamine in bipolar disorder publication-title: Bipolar Disord. – volume: 89 start-page: 499 year: 2023 end-page: 507 ident: b0440 article-title: The future is 2D: spectral-temporal fitting of dynamic MRS data provides exponential gains in precision over conventional approaches publication-title: Magn. Reson. Med. – volume: 81 start-page: 886 year: 2017 end-page: 897 ident: b0210 article-title: Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine publication-title: Biol. Psychiatry – volume: 2 start-page: 1 year: 2011 end-page: 7 ident: b0195 article-title: Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder publication-title: Front. Psych. – volume: 79 start-page: 1209 year: 2022 end-page: 1216 ident: b0360 article-title: Evaluation of Prefrontal γ-Aminobutyric Acid and Glutamate Levels in Individuals With Major Depressive Disorder Using Proton Magnetic Resonance Spectroscopy publication-title: JAMA Psychiat. – volume: 65 start-page: 289 year: 2009 end-page: 295 ident: b0370 article-title: Increased Anterior Cingulate Cortical Activity in Response to Fearful Faces: A Neurophysiological Biomarker that Predicts Rapid Antidepressant Response to Ketamine publication-title: Biol. Psychiatry – volume: 60 start-page: 29 year: 2012 end-page: 41 ident: b0350 article-title: In vivo Magnetic Resonance Spectroscopy of GABA: A methodological review publication-title: Prog. Nucl. Magn. Reson. Spectrosc. – volume: 27 start-page: 660 year: 2017 end-page: 679 ident: b0355 article-title: A computational model of major depression: The role of glutamate dysfunction on cingulo-frontal network dynamics publication-title: Cereb. Cortex – volume: 12 start-page: 415 year: 2009 end-page: 422 ident: b0050 article-title: Proton MR Spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: Correlates and predictors of treatment response publication-title: Int. J. Neuropsychopharmacol. – volume: 359 start-page: 312 year: 2019 end-page: 319 ident: b0090 article-title: Neuronal glutamatergic changes and peripheral markers of cytoskeleton dynamics change synchronically 24 h after sub-anaesthetic dose of ketamine in healthy subjects publication-title: Behav. Brain Res. – volume: 17 start-page: 2921 year: 1997 end-page: 2927 ident: b0265 article-title: Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex publication-title: J. Neurosci. – volume: 21 start-page: 320 year: 2016 end-page: 327 ident: b0255 article-title: A pilot in vivo proton Magnetic Resonance Spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder publication-title: Mol. Psychiatry – volume: 16 start-page: 2034 year: 1996 end-page: 2043 ident: b0145 article-title: NMDA-dependent modulation of CA1 local circuit inhibition publication-title: J. Neurosci. – volume: 56 start-page: 317 year: 2004 end-page: 322 ident: b0175 article-title: Increased Neurogenesis in a Rat Ketamine Model of Schizophrenia publication-title: Biol. Psychiatry – volume: 34 start-page: 1 year: 2021 end-page: 18 ident: b0320 article-title: Advanced single voxel 1H Magnetic Resonance Spectroscopy techniques in humans: Experts’ consensus recommendations publication-title: NMR Biomed. – volume: 84 start-page: 152 year: 2018 end-page: 159 ident: b0015 article-title: The effects of serotonin modulation on medial prefrontal connectivity strength and stability: A pharmacological fMRI study with citalopram publication-title: Prog. Neuro-Psychopharmacology Biol. Psychiatry – volume: 19 start-page: 907 year: 2009 end-page: 909 ident: b0395 article-title: Selective Serotonin Reuptake Inhibitors (SSRI) Pathway publication-title: Pharmacogenet. Genomics – volume: 117 start-page: 108 year: 2019 end-page: 115 ident: b0065 article-title: Ketamine induced changes in regional cerebral blood flow, interregional connectivity patterns, and glutamate metabolism publication-title: J. Psychiatr. Res. – volume: 17 start-page: 450 year: 2023 end-page: 460 ident: b0435 article-title: Cingulate prediction of response to antidepressant and cognitive behavioral therapies for depression: Meta-analysis and empirical application publication-title: Brain Imaging Behav. – reference: Clarke, W.T., Ligneul, C., Cottaar, M., Jbabdi, S., 2022. Dynamic fitting of functional MRS, diffusion weighted MRS, and edited MRS using a single interface [conference abstract], in: International Society for Magnetic Resonance in Medicine. – volume: 75 start-page: 11 year: 2018 end-page: 19 ident: b0165 article-title: Utility of imaging-based biomarkers for glutamate-targeted drug development in psychotic disorders: A randomized clinical trial publication-title: JAMA Psychiatry – year: 2022 ident: b0085 article-title: Dynamic fitting of functional MRS, diffusion weighted MRS, and edited MRS using a single interface [conference abstract] – volume: 19 start-page: 907 year: 2009 end-page: 909 ident: b0395 article-title: Selective Serotonin Reuptake Inhibitors (SSRI) Pathway publication-title: Pharmacogenet Genomics – volume: 23 start-page: 59 year: 2017 end-page: 69 ident: b0185 article-title: The effects of ketamine on dopaminergic function : meta-analysis and review of the implications for neuropsychiatric disorders publication-title: Nat. Publ. Gr. – volume: 2 start-page: 1 year: 2011 end-page: 7 ident: b0195 article-title: Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder publication-title: Front. Psychiatry – volume: 11 start-page: 1 year: 2020 end-page: 11 ident: b0405 article-title: Effect of Ketamine on Limbic GABA and Glutamate: A Human In Vivo Multivoxel Magnetic Resonance Spectroscopy Study publication-title: Front. Psychiatry – volume: 232 start-page: 501 year: 2015 end-page: 507 ident: b0130 article-title: Neurochemistry of major depression: A study using Magnetic Resonance Spectroscopy publication-title: Psychopharmacology (Berl). – volume: 79 start-page: 1209 year: 2022 end-page: 1216 ident: b0360 article-title: Evaluation of Prefrontal γ-Aminobutyric Acid and Glutamate Levels in Individuals With Major Depressive Disorder Using Proton Magnetic Resonance Spectroscopy publication-title: JAMA Psychiatry – volume: 75 start-page: 547 year: 2018 end-page: 554 ident: b0345 article-title: Pretreatment rostral anterior cingulate cortex theta activity in relation to symptom improvement in depression: A randomized clinical trial publication-title: JAMA Psychiatry – volume: 60 start-page: 29 year: 2012 end-page: 41 ident: b0350 article-title: In vivo Magnetic Resonance Spectroscopy of GABA: A methodological review. Prog Nucl Magn Reson publication-title: Spectrosc In. – volume: 228 start-page: 157 year: 2013 end-page: 166 ident: b0125 article-title: Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism publication-title: Psychopharmacology (Berl). – volume: 9 year: 2018 ident: b0425 article-title: Functional Magnetic Resonance Spectroscopy: The “new” MRS for cognitive neuroscience and psychiatry research publication-title: Front. Psychiatry – volume: 5 start-page: 675 year: 1999 end-page: 682 ident: b0240 article-title: Reciprocal Limbic-Cortical Function and Negative Mood : Converging PET Findings in Depression and Normal Sadness publication-title: Am. J. Psychiatry – volume: 17 start-page: 450 year: 2023 end-page: 460 ident: b0435 article-title: Cingulate prediction of response to antidepressant and cognitive behavioral therapies for depression: Meta-analysis and empirical application publication-title: Brain Imaging Behav – volume: 210 year: 2020 ident: b0335 article-title: Brain GABA and glutamate levels across pain conditions : A systematic literature review and meta-analysis of 1H-MRS studies using the MRS-Q quality assessment tool publication-title: Neuroimage – volume: 22 start-page: 409 year: 2004 end-page: 418 ident: b0400 article-title: Limbic – frontal circuitry in major depression : a path modeling metanalysis publication-title: Neuroimage – volume: 9 start-page: 1 year: 2018 end-page: 10 ident: b0055 article-title: Glutamate levels and resting cerebral blood flow in anterior cingulate cortex are associated at rest and immediately following infusion of S-ketamine in healthy volunteers publication-title: Front. Psychiatry – volume: 62 start-page: 1006 year: 2009 end-page: 1012 ident: b0270 article-title: Preferred Reporting Items for Systematic Reviews and Meta-Analyses : The PRISMA Statement publication-title: J. Clin. Epidemiol. – volume: 11 start-page: 1 year: 2020 ident: 10.1016/j.nicl.2023.103517_b0405 article-title: Effect of Ketamine on Limbic GABA and Glutamate: A Human In Vivo Multivoxel Magnetic Resonance Spectroscopy Study publication-title: Front. Psych. – volume: 21 start-page: 988 year: 2018 ident: 10.1016/j.nicl.2023.103517_b0135 article-title: Predicting Treatment Response in Depression: The Role of Anterior Cingulate Cortex publication-title: Int. J. Neuropsychopharmacol. doi: 10.1093/ijnp/pyy069 – volume: 62 start-page: 407 year: 2007 ident: 10.1016/j.nicl.2023.103517_b0075 article-title: Brain Imaging Correlates of Depressive Symptom Severity and Predictors of Symptom Improvement After Antidepressant Treatment publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2006.09.018 – volume: 15 start-page: 1541 year: 2012 ident: 10.1016/j.nicl.2023.103517_b0445 article-title: Early increase in marker of neuronal integrity with antidepressant treatment of major depression: 1H-Magnetic Resonance Spectroscopy of N-acetyl-aspartate publication-title: Int. J. Neuropsychopharmacol. doi: 10.1017/S1461145712000272 – volume: 62 start-page: 63 year: 2012 ident: 10.1016/j.nicl.2023.103517_b0385 article-title: Towards a glutamate hypothesis of depression: An emerging frontier of neuropsychopharmacology for mood disorders publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2011.07.036 – volume: 15 start-page: 1 year: 2021 ident: 10.1016/j.nicl.2023.103517_b0020 article-title: Effect of Ketamine on Human Neurochemistry in Posterior Cingulate Cortex: A Pilot Magnetic Resonance Spectroscopy Study at 3 Tesla publication-title: Front. Neurosci. doi: 10.3389/fnins.2021.609485 – volume: 47 start-page: 351 year: 2000 ident: 10.1016/j.nicl.2023.103517_b0030 article-title: Antidepressant effects of ketamine in depressed patients publication-title: Biol. Psychiatry doi: 10.1016/S0006-3223(99)00230-9 – volume: 79 start-page: 1209 year: 2022 ident: 10.1016/j.nicl.2023.103517_b0360 article-title: Evaluation of Prefrontal γ-Aminobutyric Acid and Glutamate Levels in Individuals With Major Depressive Disorder Using Proton Magnetic Resonance Spectroscopy publication-title: JAMA Psychiat. doi: 10.1001/jamapsychiatry.2022.3384 – volume: 159 start-page: 663 year: 2002 ident: 10.1016/j.nicl.2023.103517_b0380 article-title: Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.159.4.663 – volume: 359 start-page: 312 year: 2019 ident: 10.1016/j.nicl.2023.103517_b0090 article-title: Neuronal glutamatergic changes and peripheral markers of cytoskeleton dynamics change synchronically 24 h after sub-anaesthetic dose of ketamine in healthy subjects publication-title: Behav. Brain Res. doi: 10.1016/j.bbr.2018.10.021 – volume: 23 start-page: 59 year: 2017 ident: 10.1016/j.nicl.2023.103517_b0185 article-title: The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders publication-title: Nat. Publ. Gr. – volume: 232 year: 2021 ident: 10.1016/j.nicl.2023.103517_b0420 article-title: Effects of SSRI treatment on GABA and glutamate levels in an associative relearning paradigm publication-title: Neuroimage doi: 10.1016/j.neuroimage.2021.117913 – volume: 22 start-page: 562 year: 2017 ident: 10.1016/j.nicl.2023.103517_b0200 article-title: Ketamine modulates hippocampal neurochemistry and functional connectivity: A combined Magnetic Resonance Spectroscopy and resting-state fMRI study in healthy volunteers publication-title: Mol. Psychiatry doi: 10.1038/mp.2016.122 – volume: 48 start-page: 830 year: 2000 ident: 10.1016/j.nicl.2023.103517_b0245 article-title: Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response publication-title: Biol. Psychiatry doi: 10.1016/S0006-3223(00)01036-2 – volume: 86 start-page: 903 year: 1997 ident: 10.1016/j.nicl.2023.103517_b0310 article-title: Multiple Mechanisms of Ketamine Blockade of N-methyl-D-aspartate Receptors publication-title: Anesthesiology doi: 10.1097/00000542-199704000-00021 – volume: 529 start-page: 17 year: 2017 ident: 10.1016/j.nicl.2023.103517_b0170 article-title: B0 magnetic field homogeneity and shimming for in vivo Magnetic Resonance Spectroscopy publication-title: Anal. Biochem. doi: 10.1016/j.ab.2016.06.003 – volume: 117 start-page: 2656 year: 2020 ident: 10.1016/j.nicl.2023.103517_b0180 article-title: Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents publication-title: PNAS doi: 10.1073/pnas.1916570117 – volume: 16 start-page: 2034 year: 1996 ident: 10.1016/j.nicl.2023.103517_b0145 article-title: NMDA-dependent modulation of CA1 local circuit inhibition publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.16-06-02034.1996 – volume: 27 start-page: 660 year: 2017 ident: 10.1016/j.nicl.2023.103517_b0355 article-title: A computational model of major depression: The role of glutamate dysfunction on cingulo-frontal network dynamics publication-title: Cereb. Cortex – volume: 37 start-page: 2554 year: 2012 ident: 10.1016/j.nicl.2023.103517_b0230 article-title: Metabolic pathways and activity-dependent modulation of glutamate concentration in the human brain publication-title: Neurochem. Res. doi: 10.1007/s11064-012-0848-4 – volume: 22 start-page: 409 year: 2004 ident: 10.1016/j.nicl.2023.103517_b0400 article-title: Limbic – frontal circuitry in major depression: a path modeling metanalysis publication-title: Neuroimage doi: 10.1016/j.neuroimage.2004.01.015 – volume: 63 start-page: 793 year: 2006 ident: 10.1016/j.nicl.2023.103517_b0480 article-title: A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression publication-title: Arch. Gen. Psychiatry doi: 10.1001/archpsyc.63.8.856 – volume: 43 start-page: 2154 year: 2018 ident: 10.1016/j.nicl.2023.103517_b0005 article-title: The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects publication-title: Neuropsychopharmacology doi: 10.1038/s41386-018-0136-3 – volume: 45 start-page: 651 year: 2005 ident: 10.1016/j.nicl.2023.103517_b0250 article-title: Deep Brain Stimulation for Treatment-Resistant Depression ing electrical stimulation of the subgenual cingulate publication-title: Neuron doi: 10.1016/j.neuron.2005.02.014 – volume: 9 year: 2018 ident: 10.1016/j.nicl.2023.103517_b0425 article-title: Functional Magnetic Resonance Spectroscopy: The “new” MRS for cognitive neuroscience and psychiatry research publication-title: Front. Psych. – volume: 84 start-page: 152 year: 2018 ident: 10.1016/j.nicl.2023.103517_b0015 article-title: The effects of serotonin modulation on medial prefrontal connectivity strength and stability: A pharmacological fMRI study with citalopram publication-title: Prog. Neuro-Psychopharmacology Biol. Psychiatry doi: 10.1016/j.pnpbp.2018.01.021 – volume: 117 start-page: 108 year: 2019 ident: 10.1016/j.nicl.2023.103517_b0065 article-title: Ketamine induced changes in regional cerebral blood flow, interregional connectivity patterns, and glutamate metabolism publication-title: J. Psychiatr. Res. doi: 10.1016/j.jpsychires.2019.07.008 – volume: 35 start-page: 601 year: 2015 ident: 10.1016/j.nicl.2023.103517_b0025 article-title: Neurochemical and BOLD responses during neuronal activation measured in the human visual cortex at 7 Tesla publication-title: J. Cereb. Blood Flow Metab. doi: 10.1038/jcbfm.2014.233 – volume: 698 start-page: 228 year: 2014 ident: 10.1016/j.nicl.2023.103517_b0260 article-title: Sub-anesthetic concentrations of (R, S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2012.11.023 – volume: 46 start-page: 1059 year: 2012 ident: 10.1016/j.nicl.2023.103517_b0140 article-title: Region-specific glutamate changes in patients with unipolar depression publication-title: J. Psychiatr. Res. doi: 10.1016/j.jpsychires.2012.04.018 – volume: 272 start-page: 703 issue: 4 year: 2022 ident: 10.1016/j.nicl.2023.103517_b0120 article-title: Acute effects of ketamine on the pregenual anterior cingulate: linking spontaneous activation, functional connectivity, and glutamate metabolism publication-title: Eur. Arch. Psychiatry Clin. Neurosci. doi: 10.1007/s00406-021-01377-2 – volume: 56 start-page: 317 year: 2004 ident: 10.1016/j.nicl.2023.103517_b0175 article-title: Increased Neurogenesis in a Rat Ketamine Model of Schizophrenia publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2004.06.010 – volume: 17 start-page: 664 year: 2012 ident: 10.1016/j.nicl.2023.103517_b0430 article-title: Ketamine effects on brain GABA and glutamate levels with 1H-MRS: Relationship to ketamine-induced psychopathology publication-title: Mol. Psychiatry doi: 10.1038/mp.2011.171 – volume: 5 start-page: 1 year: 2016 ident: 10.1016/j.nicl.2023.103517_b0315 article-title: Rayyan-a web and mobile app for systematic reviews publication-title: Syst. Rev. doi: 10.1186/s13643-016-0384-4 – volume: 22 start-page: 473 year: 2008 ident: 10.1016/j.nicl.2023.103517_b0450 article-title: Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR Spectroscopy publication-title: J. Psychopharmacol. doi: 10.1177/0269881107081510 – volume: 162 start-page: 394 year: 2005 ident: 10.1016/j.nicl.2023.103517_b0365 article-title: Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: A 4-T proton MRS study publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.162.2.394 – ident: 10.1016/j.nicl.2023.103517_b0085 – volume: 62 start-page: 1006 year: 2009 ident: 10.1016/j.nicl.2023.103517_b0270 article-title: Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement publication-title: J. Clin. Epidemiol. doi: 10.1016/j.jclinepi.2009.06.005 – volume: 6 start-page: 369 year: 2012 ident: 10.1016/j.nicl.2023.103517_b0010 article-title: Treatment-resistant depression: Therapeutic trends, challenges, and future directions publication-title: Patient Prefer. Adherence doi: 10.2147/PPA.S29716 – volume: 30 start-page: 579 year: 2016 ident: 10.1016/j.nicl.2023.103517_b0235 article-title: A pilot study of the effect of short-term escitalopram treatment on brain metabolites and gamma-oscillations in healthy subjects publication-title: J. Psychopharmacol. doi: 10.1177/0269881116636108 – volume: 9 start-page: 1 year: 2018 ident: 10.1016/j.nicl.2023.103517_b0055 article-title: Glutamate levels and resting cerebral blood flow in anterior cingulate cortex are associated at rest and immediately following infusion of S-ketamine in healthy volunteers publication-title: Front. Psych. – volume: 24 start-page: 1217 year: 2010 ident: 10.1016/j.nicl.2023.103517_b0455 article-title: Lack of effect of citalopram on Magnetic Resonance Spectroscopy measures of glutamate and glutamine in frontal cortex of healthy volunteers publication-title: J. Psychopharmacol. doi: 10.1177/0269881109105679 – volume: 269 start-page: 9 year: 2017 ident: 10.1016/j.nicl.2023.103517_b0060 article-title: Acute change in anterior cingulate cortex GABA, but not glutamine/glutamate, mediates antidepressant response to citalopram publication-title: Psychiatry Res. - Neuroimaging doi: 10.1016/j.pscychresns.2017.08.009 – volume: 51 start-page: 1784 year: 2019 ident: 10.1016/j.nicl.2023.103517_b0390 article-title: Number of subjects required in common study designs for functional GABA Magnetic Resonance Spectroscopy in the human brain at 3 Tesla publication-title: Eur. J. Neurosci. doi: 10.1111/ejn.14618 – volume: 24 start-page: 952 year: 2019 ident: 10.1016/j.nicl.2023.103517_b0275 article-title: Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton Magnetic Resonance Spectroscopy studies publication-title: Mol. Psychiatry doi: 10.1038/s41380-018-0252-9 – volume: 34 start-page: e4257 year: 2021 ident: 10.1016/j.nicl.2023.103517_b0295 article-title: Preprocessing, analysis and quantification in single-voxel Magnetic Resonance Spectroscopy: experts’ consensus recommendations publication-title: NMR Biomed. doi: 10.1002/nbm.4257 – volume: 42 start-page: 1201 year: 2017 ident: 10.1016/j.nicl.2023.103517_b0215 article-title: Temporal Dynamics of Antidepressant Ketamine Effects on Glutamine Cycling Follow Regional Fingerprints of AMPA and NMDA Receptor Densities publication-title: Neuropsychopharmacology doi: 10.1038/npp.2016.184 – volume: 392 start-page: 5 year: 2006 ident: 10.1016/j.nicl.2023.103517_b0070 article-title: Enhancement of long-term potentiation at CA1-subiculum synapses in MK-801-treated rats publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2005.08.054 – volume: 102 start-page: 72 year: 2016 ident: 10.1016/j.nicl.2023.103517_b0045 article-title: BDNF - A key transducer of antidepressant effects publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2015.10.034 – volume: 64 start-page: 75 year: 2013 ident: 10.1016/j.nicl.2023.103517_b0095 article-title: Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers publication-title: Neuroimage doi: 10.1016/j.neuroimage.2012.09.037 – volume: 81 start-page: 886 issue: 10 year: 2017 ident: 10.1016/j.nicl.2023.103517_b0210 article-title: Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2016.05.005 – volume: 17 start-page: 450 issue: 4 year: 2023 ident: 10.1016/j.nicl.2023.103517_b0435 article-title: Cingulate prediction of response to antidepressant and cognitive behavioral therapies for depression: Meta-analysis and empirical application publication-title: Brain Imaging Behav. doi: 10.1007/s11682-022-00756-0 – volume: 12 start-page: 415 year: 2009 ident: 10.1016/j.nicl.2023.103517_b0050 article-title: Proton MR Spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: Correlates and predictors of treatment response publication-title: Int. J. Neuropsychopharmacol. doi: 10.1017/S1461145708009516 – volume: 89 start-page: 499 year: 2023 ident: 10.1016/j.nicl.2023.103517_b0440 article-title: The future is 2D: spectral-temporal fitting of dynamic MRS data provides exponential gains in precision over conventional approaches publication-title: Magn. Reson. Med. doi: 10.1002/mrm.29456 – volume: 19 start-page: 907 year: 2009 ident: 10.1016/j.nicl.2023.103517_b0395 article-title: Selective Serotonin Reuptake Inhibitors (SSRI) Pathway publication-title: Pharmacogenet. Genomics doi: 10.1097/FPC.0b013e32833132cb – volume: 39 start-page: 7968 year: 2019 ident: 10.1016/j.nicl.2023.103517_b0035 article-title: Comparison of neurochemical and BOLD signal contrast response functions in the human visual cortex publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.3021-18.2019 – volume: 33 start-page: 12698 year: 2013 ident: 10.1016/j.nicl.2023.103517_b0100 article-title: Systematic regional variations of GABA, glutamine, and glutamate concentrations follow receptor fingerprints of human cingulate cortex publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.1758-13.2013 – volume: 161 start-page: 368 year: 2004 ident: 10.1016/j.nicl.2023.103517_b0040 article-title: Increased Brain GABA Concentrations Following Acute Administration of a Selective Serotonin Reuptake Inhibitor publication-title: Am. J. Psychiatry doi: 10.1176/appi.ajp.161.2.368 – volume: 27 start-page: 11496 year: 2007 ident: 10.1016/j.nicl.2023.103517_b0155 article-title: NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2213-07.2007 – volume: 36 start-page: 183 year: 2011 ident: 10.1016/j.nicl.2023.103517_b0340 article-title: Frontocingulate dysfunction in depression: Toward biomarkers of treatment response publication-title: Neuropsychopharmacology doi: 10.1038/npp.2010.166 – volume: 16 start-page: 119 issue: 2 year: 2014 ident: 10.1016/j.nicl.2023.103517_b0305 article-title: Neural correlates of rapid antidepressant response to ketamine in bipolar disorder publication-title: Bipolar Disord. doi: 10.1111/bdi.12118 – volume: 44 start-page: 1 year: 2004 ident: 10.1016/j.nicl.2023.103517_b0465 article-title: Stereoselective effects of ketamine on dopamine, serotonin and noradrenaline release and uptake in rat brain slices publication-title: Neurochem. Int. doi: 10.1016/S0197-0186(03)00104-9 – volume: 12 start-page: 527 year: 2002 ident: 10.1016/j.nicl.2023.103517_b0110 article-title: Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/S0924-977X(02)00102-5 – volume: 232 start-page: 501 year: 2015 ident: 10.1016/j.nicl.2023.103517_b0130 article-title: Neurochemistry of major depression: A study using Magnetic Resonance Spectroscopy publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-014-3687-y – volume: 86 start-page: 43 year: 2014 ident: 10.1016/j.nicl.2023.103517_b0285 article-title: Current practice in the use of MEGA-PRESS Spectroscopy for the detection of GABA publication-title: Neuroimage doi: 10.1016/j.neuroimage.2012.12.004 – volume: 266 year: 2023 ident: 10.1016/j.nicl.2023.103517_b0205 article-title: A mean-field model of glutamate and GABA synaptic dynamics for functional MRS publication-title: Neuroimage doi: 10.1016/j.neuroimage.2022.119813 – volume: 71 start-page: 1022 year: 2012 ident: 10.1016/j.nicl.2023.103517_b0080 article-title: 1H-[13C]-nuclear Magnetic Resonance Spectroscopy measures of ketamine’s effect on amino acid neurotransmitter metabolism publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2011.11.006 – volume: 191 start-page: 122 year: 2011 ident: 10.1016/j.nicl.2023.103517_b0470 article-title: The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS publication-title: Psychiatry Res. - Neuroimaging doi: 10.1016/j.pscychresns.2010.10.009 – volume: 68 start-page: 780 issue: 9 year: 2010 ident: 10.1016/j.nicl.2023.103517_b0375 article-title: Magnetic Resonance Spectroscopy studies of the glutamatergic system in mood disorders: A pathway to diagnosis, novel therapeutics, and personalized medicine? Biol publication-title: Psychiatry – volume: 42 start-page: 911 year: 2022 ident: 10.1016/j.nicl.2023.103517_b0190 article-title: Human brain functional MRS reveals interplay of metabolites implicated in neurotransmission and neuroenergetics publication-title: J. Cereb. Blood Flow Metab. doi: 10.1177/0271678X221076570 – volume: 26 start-page: 733 year: 2012 ident: 10.1016/j.nicl.2023.103517_b0460 article-title: Lack of effect of ketamine on cortical glutamate and glutamine in healthy volunteers: A proton Magnetic Resonance Spectroscopy study publication-title: J. Psychopharmacol. doi: 10.1177/0269881111405359 – volume: 34 start-page: 1 year: 2021 ident: 10.1016/j.nicl.2023.103517_b0320 article-title: Advanced single voxel 1H Magnetic Resonance Spectroscopy techniques in humans: Experts’ consensus recommendations publication-title: NMR Biomed. doi: 10.1002/nbm.4236 – volume: 228 start-page: 157 year: 2013 ident: 10.1016/j.nicl.2023.103517_b0125 article-title: Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-013-3024-x – volume: 142 start-page: 30 year: 2018 ident: 10.1016/j.nicl.2023.103517_b0160 article-title: Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2018.06.008 – volume: 29 start-page: 441 year: 2009 ident: 10.1016/j.nicl.2023.103517_b0225 article-title: Metabolic and hemodynamic events after changes in neuronal activity: Current hypotheses, theoretical predictions and in vivo NMR experimental findings publication-title: J. Cereb. Blood Flow Metab. doi: 10.1038/jcbfm.2008.134 – volume: 17 start-page: 2921 year: 1997 ident: 10.1016/j.nicl.2023.103517_b0265 article-title: Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.17-08-02921.1997 – volume: 26 start-page: 545 year: 2016 ident: 10.1016/j.nicl.2023.103517_b0150 article-title: Acute Metabolic Changes Associated With Analgesic Drugs: An MR Spectroscopy Study publication-title: J. Neuroimaging doi: 10.1111/jon.12345 – volume: 26 start-page: 642 year: 2005 ident: 10.1016/j.nicl.2023.103517_b0280 article-title: A novel technique to study the brain’s response to pain: Proton Magnetic Resonance Spectroscopy publication-title: Neuroimage doi: 10.1016/j.neuroimage.2005.02.001 – volume: 60 start-page: 29 year: 2012 ident: 10.1016/j.nicl.2023.103517_b0350 article-title: In vivo Magnetic Resonance Spectroscopy of GABA: A methodological review publication-title: Prog. Nucl. Magn. Reson. Spectrosc. doi: 10.1016/j.pnmrs.2011.06.001 – volume: 29 start-page: 23 year: 1996 ident: 10.1016/j.nicl.2023.103517_b0410 article-title: Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: Implications for the pharmacotherapy of depression publication-title: Pharmacopsychiatry doi: 10.1055/s-2007-979537 – volume: 43 start-page: 1908 issue: 9 year: 2018 ident: 10.1016/j.nicl.2023.103517_b0115 article-title: 7T 1 H-MRS in major depressive disorder: A Ketamine Treatment Study publication-title: Neuropsychopharmacology doi: 10.1038/s41386-018-0057-1 – volume: 8 year: 2018 ident: 10.1016/j.nicl.2023.103517_b0300 article-title: Ketamine and selective activation of parvalbumin interneurons inhibit stress-induced dendritic spine elimination publication-title: Transl. Psychiatry doi: 10.1038/s41398-018-0321-5 – volume: 279 start-page: 417 year: 2021 ident: 10.1016/j.nicl.2023.103517_b0415 article-title: Neurotransmitters and Neurometabolites in Late-Life Depression: A Preliminary Magnetic Resonance Spectroscopy Study at 7T publication-title: J. Affect. Disord. doi: 10.1016/j.jad.2020.10.011 – volume: 27 start-page: 3833 year: 2022 ident: 10.1016/j.nicl.2023.103517_b0290 article-title: Does the change in glutamate to GABA ratio correlate with change in depression severity? A randomized, double-blind clinical trial publication-title: Mol. Psychiatry doi: 10.1038/s41380-022-01730-4 – volume: 65 start-page: 289 issue: 4 year: 2009 ident: 10.1016/j.nicl.2023.103517_b0370 article-title: Increased Anterior Cingulate Cortical Activity in Response to Fearful Faces: A Neurophysiological Biomarker that Predicts Rapid Antidepressant Response to Ketamine publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2008.08.014 – volume: 5 start-page: 675 year: 1999 ident: 10.1016/j.nicl.2023.103517_b0240 article-title: Reciprocal Limbic-Cortical Function and Negative Mood: Converging PET Findings in Depression and Normal Sadness publication-title: Am. J. Psychiatry doi: 10.1176/ajp.156.5.675 – volume: 30 start-page: 2336 year: 2009 ident: 10.1016/j.nicl.2023.103517_b0325 article-title: Receptor Architecture of Human Cingulate Cortex: Evaluation of the Four-Region Neurobiological Model publication-title: Hum. Brain Mapp. doi: 10.1002/hbm.20667 – volume: 266 start-page: 572 year: 2020 ident: 10.1016/j.nicl.2023.103517_b0105 article-title: Glutamatergic and GABA-ergic abnormalities in First-episode depression. A 1-year follow-up 1H-MR Spectroscopic study publication-title: J. Affect. Disord. doi: 10.1016/j.jad.2020.01.138 – volume: 2 start-page: 1 year: 2011 ident: 10.1016/j.nicl.2023.103517_b0195 article-title: Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder publication-title: Front. Psych. – volume: 21 start-page: 320 year: 2016 ident: 10.1016/j.nicl.2023.103517_b0255 article-title: A pilot in vivo proton Magnetic Resonance Spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder publication-title: Mol. Psychiatry doi: 10.1038/mp.2015.83 – volume: 75 start-page: 547 year: 2018 ident: 10.1016/j.nicl.2023.103517_b0345 article-title: Pretreatment rostral anterior cingulate cortex theta activity in relation to symptom improvement in depression: A randomized clinical trial publication-title: JAMA Psychiat. doi: 10.1001/jamapsychiatry.2018.0252 – volume: 75 start-page: 11 year: 2018 ident: 10.1016/j.nicl.2023.103517_b0165 article-title: Utility of imaging-based biomarkers for glutamate-targeted drug development in psychotic disorders: A randomized clinical trial publication-title: JAMA Psychiat. doi: 10.1001/jamapsychiatry.2017.3572 – volume: 34 start-page: 1 year: 2021 ident: 10.1016/j.nicl.2023.103517_b0220 article-title: Minimum Reporting Standards for in vivo Magnetic Resonance Spectroscopy (MRSinMRS): Experts’ consensus recommendations publication-title: NMR Biomed. doi: 10.1002/nbm.4484 – volume: 68 start-page: 785 year: 2010 ident: 10.1016/j.nicl.2023.103517_b0475 article-title: Magnetic Resonance Spectroscopy studies of glutamate-related abnormalities in mood disorders publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2010.06.016 – volume: 210 year: 2020 ident: 10.1016/j.nicl.2023.103517_b0330 article-title: Brain GABA and glutamate levels across pain conditions: A systematic literature review and meta-analysis of 1H-MRS studies using the MRS-Q quality assessment tool publication-title: Neuroimage doi: 10.1016/j.neuroimage.2020.116532 |
| SSID | ssj0000800766 |
| Score | 2.3105907 |
| SecondaryResourceType | review_article |
| Snippet | •SSRIs and SNRIs do not consistently affect Glu/GABA systems in 1H-MRS studies.•Amidst null findings, we find some evidence that (es)ketamine increases ACC... Highlights•SSRIs and SNRIs do not consistently affect Glu/GABA systems in 1H-MRS studies. •Amidst null findings, we find some evidence that (es)ketamine... Selective serotonin reuptake inhibitors (SSRIs), serotonin and noradrenaline reuptake inhibitors (SNRIs), and (es)ketamine are used to treat major depressive... • SSRIs and SNRIs do not consistently affect Glu/GABA systems in 1 H-MRS studies. • Amidst null findings, we find some evidence that (es)ketamine increases ACC... |
| SourceID | doaj pubmedcentral proquest crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 103517 |
| SubjectTerms | (es)ketamine 1H-MRS GABA Glutamate Major Depressive Disorder Radiology Review SNRI SSRI |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hHBAXBBSEaam2Um_IEHsf3uXWIqqoUjlQKvW2Wu-DJAIH1e7_Z_bhNJZQc-EWJV7bmpnd-SYz8w1Cpw0EsrytdOlrwksqjSi1caL0njJhpG8qH6t8v_HFDb28Zbc7o75CTViiB06C--SshKjAc0O0BnuzGhAudRZgO2yPSrtw-oLP2wmm1hkHNZznLplU0BWYZj-GaeGh0ZzFCWUPnigS9k8c0g7gnJZL7vifixfoeQaO-Cy98Ev0xHWv0NOrnBo_QMtIs_HbDaDV0FeMU0tvj1cdvkuFsA4PGwySXOXyV_iIY249auczPsMPvM449bTgjcfVorz6fo1jdrv72b9GNxdff3xZlHmMQmkYYUNJbfDZwhNLTU20kIBynG8b5xrhWGOEmUvLhJ5bbywAEmIBhEhOpTa0NQ0hb9Cs23TuLcKGcKoZgbvomhpphaTei9a0VkPYQ0iBqlGkymSO8TDq4pcai8nWKqhBBTWopIYCfdiu-ZMYNh69-jxoantlYMeOX4DNqGwzap_NFIiMelZjAyocmXCj1aOPbv61yvV51_eqUn2t5uq6ritSMYBeJM1ALRDbrszAJgGWvU88GY1Qwa4PqRzduc19r-oQZoacOC-QmFjnRDLTX7rVMvKHA6TmcMyTd_9DlofoWXjj9K_UEZoNd_fuPeC0oT2OW_IvCFE8og priority: 102 providerName: Directory of Open Access Journals – databaseName: ScienceDirect Open Access Journals (Elsevier) dbid: IXB link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9UwELaqHhAXxCrCJiNxQ-a9xHZic6MV1RNSOVAqvZvleGmDIKle0v_PeMlrI1CRuGWxE8sz-WYmsyH0rgFDtm5LTXxFa8KkEUQbJ4j3jAsjfVP6GOX7td6csy9bvj1Ax3MuTAirzNifMD2idb6yyru5uuq61VlVlbTkIOBo6jQJOEyZiEl826P9f5agETXRZRnGkzAh586kMK9Qf_ZD6CEe0s957Ft2I59iGf-FmLqlhi6DKG9JpZOH6EFWJ_GntOJH6MD1j9G90-wwf4IuY_GNX24CWodsY5wSfUfc9XiXwmMdngYM-9vloFg4xNHjHmn2EWt8U-0Zp0wXPHhcbsjptzMcfd79xfgUnZ98_n68Ibm5AjGc8okwGyS58NQyU1EtJOg-zreNc41wvDHCrKXlQq-tNxbUFGpBNZE1k9qw1jSUPkOH_dC75wgbWjPNKTxFV8xIKyTzXrSmtRqMIUoLVM5bqkyuPB4aYPxUc4jZDxXIoAIZVCJDgd7v51yluht3jj4KlNqPDDWz44Vhd6Ey0yhnJdiXvjawTkAuq8FWYs6CAQhAW2pXIDrTWc1pqQCk8KDuzlc3f5vlxowFoyrVWKm1-oNfC8T3Mxcs_883vp2ZUAEWBAeP7t1wPaoqGJ_BU14XSCy4c7Ezyzt9dxmrioOiXQP40xf_uayX6H44S7-nXqHDaXftXoPCNrVv4hf5Gz-7PqE priority: 102 providerName: Elsevier |
| Title | Neurometabolite changes in response to antidepressant medication: A systematic review of 1H-MRS findings |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2213158223002085 https://www.clinicalkey.es/playcontent/1-s2.0-S2213158223002085 https://dx.doi.org/10.1016/j.nicl.2023.103517 https://www.proquest.com/docview/2875380656 https://pubmed.ncbi.nlm.nih.gov/PMC10563053 https://doaj.org/article/ed9282f6c3aa400da6754ed6258871ae |
| Volume | 40 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swEBddB2MvZZ_M21o02NtwiS3JkgujtGMlG2QP6wJ5E7I-2pTWXmMX1v9-J1lOawgdewmJY8nm7qT7ne4LoY8cDNmiylTqclKktNQiVdqK1DnKhC4dz1yI8v1RTOf0-4ItttDQ7igSsN1o2vl-UvPV5f6f69tDWPCf72K1fBHZfd8I3OeQs4w_Qo9BM3HfymEW4f5FREc8uC_zPCNpxkQe82g2TzPSVaGk_0hl3YOk44DKexrq5BnaidASH_Wy8Bxt2foFejKLzvOX6DwU4riyHfDdZx7jPum3xcsar_pQWYu7BgOtlzFAFr7i4H0P_DvAR_iu8jPus15w43A2TWc_T3Hwf9dn7Ss0P_n668s0jY0WUs0I61JqvFYXjhiqc6JECTjIuopby4VlXAs9KQ0TamKcNgBZiAGYUha0VJpWmhPyGm3XTW3fIKxJQRUjMIvKqS6NKKlzotKVUWAYEZKgbCCp1LEKuW-GcSmHcLML6dkgPRtkz4YEfVqP-d3X4Hjw7mPPqfWdvn52uNCszmRcjtKaEmxNV2h4T9jFjAK7iVoDxiBsupmyCSIDn-WQogqbKky0fPDRfNMo2w5iLTPZ5nIiT738efEDAzB0SU0QW4-M0KeHNP984odBCCXsC97Zo2rb3LQy94ao95oXCRIj6RxRZvxPvTwPFcYBdBegCMjb_6L8O_TU_-oPqN6j7W51Y3cBsnXVXjjqgM9vi-O9sCb_AgSWQEg |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkaAXxFMNTyNxQ2E3sZ043GhFtYVuD7SV9mY5frRBNKk26f9n_Mi2EahI3KIkk1ieyTczmRdCH0pwZIs6k6nNSZHSSvFUKsNTaynjqrJlZn2W73GxOKPfVmy1hfbHWhiXVhmxP2C6R-t4ZhZ3c3bVNLOTPM9IxkDBkTBp8h66D9ZA4UT7cLW3-dHiTKLSxywdQeooYvFMyPNyDWg_uSHirv6c-cFlNwrK9_Gf6Klbdug0i_KWWjp4jB5FexJ_CUt-grZM-xQ9WMaI-TN04btvXJoBmO3KjXGo9O1x0-J1yI81eOgwbHATs2LhEPuQu2faZyzxTbtnHEpdcGdxtkiXP06wD3q35_1zdHbw9XR_kcbpCqlihA0p1U6Vc0s0VTmRvALjx9i6NKbkhpWKq3mlGZdzbZUGO4VosE2qglZS0VqVhLxA223Xml2EFSmoZASeInOqKs0rai2vVa0leEOEJCgbt1So2HrcTcD4JcYcs5_CsUE4NojAhgR93NBchcYbd9695zi1udM1zfYnuvW5iFIjjK7AwbSFgnUCdGkJzhI1GjxAQNpMmgSRkc9irEsFJIUHNXe-uvwblekjGPQiE30u5uIPgU0Q21BOZP6fb3w_CqEAMHARHtma7roXufM-Xai8SBCfSOdkZ6ZX2ubCtxUHS7sA9Ccv_3NZ79DDxenySBwdHn9_hXbclfCv6jXaHtbX5g1Yb0P91n-dvwFSvkHI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neurometabolite+changes+in+response+to+antidepressant+medication%3A+A+systematic+review+of+1H-MRS+findings&rft.jtitle=NeuroImage+clinical&rft.au=Boucherie%2C+Daphne+E.&rft.au=Reneman%2C+Liesbeth&rft.au=Ruh%C3%A9%2C+Henricus+G.&rft.au=Schrantee%2C+Anouk&rft.date=2023-01-01&rft.issn=2213-1582&rft.eissn=2213-1582&rft.volume=40&rft.spage=103517&rft_id=info:doi/10.1016%2Fj.nicl.2023.103517&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_nicl_2023_103517 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F22131582%2Fcov200h.gif |